Carole A. Sable
Chief Tech/Sci/R&D Officer chez VITAE PHARMACEUTICALS INC
Profil
Carole A.
Sable is a professional with a doctorate degree from Sidney Kimmel Medical College and Thomas Jefferson University.
She is currently the Director at Basilea Pharmaceutica AG since 2023 and the Chief Medical Officer at Vitae Pharmaceuticals LLC since 2016.
Her former jobs include Executive Director-Clinical Research at Merck & Co., Inc. from 1995 to 2007, Assistant Professor at the University of Virginia from 1993 to 1995, Vice President at Merck & Co., Inc. from 2010 to 2013, and Chief Medical Officer at SCYNEXIS, Inc. from 2014 to 2015.
She also held the position of Chief Medical Officer at Novexel SA and Revolution Medicines, Inc.
Postes actifs de Carole A. Sable
| Sociétés | Poste | Début |
|---|---|---|
| VITAE PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 06/06/2016 |
| BASILEA PHARMACEUTICA AG | Director/Board Member | 27/04/2023 |
Anciens postes connus de Carole A. Sable
| Sociétés | Poste | Fin |
|---|---|---|
| SCYNEXIS, INC. | Chief Tech/Sci/R&D Officer | 20/02/2015 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2013 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2007 |
| University of Virginia | Corporate Officer/Principal | 01/01/1995 |
| REVOLUTION MEDICINES, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Carole A. Sable
| Thomas Jefferson University | Doctorate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SCYNEXIS, INC. | Health Technology |
| BASILEA PHARMACEUTICA AG | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Novexel SA
 Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Health Technology |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
